MARKET

MGTX

MGTX

Meiragtx Holdings Plc
NASDAQ
8.61
-0.19
-2.10%
Opening 09:51 11/13 EST
OPEN
8.80
PREV CLOSE
8.79
HIGH
8.80
LOW
8.60
VOLUME
94.63K
TURNOVER
--
52 WEEK HIGH
15.35
52 WEEK LOW
6.62
MARKET CAP
826.45M
P/E (TTM)
12.19
1D
5D
1M
3M
1Y
5Y
1D
H.C. Wainwright Keeps Their Buy Rating on Meiragtx Holdings (MGTX)
TipRanks · 12m ago
Meiragtx Holdings (MGTX) Receives a Buy from RBC Capital
TipRanks · 13m ago
MeiraGTx Holdings plc Reports Third Quarter 2026 Financial and Operational Results
NASDAQ · 8h ago
MeiraGTx files automatic mixed securities shelf
TipRanks · 1d ago
MeiraGTx Holdings PLC (MGTX) Reports Q3 Loss, Misses Revenue Estimates
NASDAQ · 1d ago
MeiraGTx Hldgs Q3 EPS $(0.53) Misses $(0.50) Estimate, Sales $4.814M Miss $6.953M Estimate
Benzinga · 1d ago
*MeiraGTx Holdings 3Q Rev $4.81M >MGTX
Dow Jones · 1d ago
*MeiraGTx Holdings 3Q Loss/Shr 53c >MGTX
Dow Jones · 1d ago
More
About MGTX
MeiraGTx Holdings PLC is a vertically integrated, clinical-stage genetic medicines company. It has a pipeline of late-stage clinical programs, including Parkinson’s disease, radiation-induced xerostomia and AIPL1-associated retinal dystrophy. It is focused on vivo delivery of vectorized biologic therapeutics addressing unmet needs in prevalent disorders, including severe forms of xerostomia, neurodegenerative diseases and ocular diseases, including inherited retinal diseases (IRDs), and large degenerative ocular diseases. The Company’s product pipeline includes Botaretigene Sparoparvovec for the treatment of X-linked Retinitis Pigmentosa; AAV-hAQP1 for the treatment of Radiation-Induced Grade 2/3 Xerostomia; AAV-hAQP1 for the treatment of Sjogren’s Syndrome; AAV-GAD for the treatment of Parkinson’s Disease; AAV-RPE65 for the treatment of RPE65-Associated Retinal Dystrophy; AAV-CNGB3 and AAV-CNGA3 for the treatment of Achromatopsia; AAV-AIPL1 for the treatment of LCA4, and others.

Webull offers MeiraGTx Holdings PLC stock information, including NASDAQ: MGTX real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, MGTX stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading MGTX stock methods without spending real money on the virtual paper trading platform.